AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

TORSEMIDE 20 Mg ;

11 registrations across 1 African market— 11 active

Markets with TORSEMIDE 20 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Torsamolex 20 mg/2ml
Solution for slow I.V injection or infusion
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
TORSAMOLEX 20 mg
Tablets
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
Torseretic 20 mg
Tablets
🇪🇬EgyptUtopia pharmaceuticalsactive
Examide 20 mg
Tablets
🇪🇬EgyptApex pharmaactive
Onced 20 mg
Tablets
🇪🇬EgyptOctober Pharmaactive
Flotorasem 20 mg
Tablets
🇪🇬EgyptGypto Pharma for Pharmaceutical Manufacturing and Trading - GYPTOactive
Torseretic
Solution for slow I.V injection or infusion
🇪🇬EgyptUtopia pharmaceuticalsactive
Torseretic
Solution for slow I.V injection or infusion
🇪🇬EgyptUtopia pharmaceuticalsactive
Onced 20 mg
Tablets
🇪🇬EgyptOctober Pharmaactive
Retorinad 20mg
Tablets
🇪🇬EgyptInternational advanced pharmaceutical industries (INAD pharma)active
Nephromide
solution for intravenous injection
🇪🇬Egyptpharaonia pharmaceuticals (pharo pharma)active

TORSEMIDE 20 Mg ; in Africa — Regulatory Overview

TORSEMIDE 20 Mg ; is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.